190 related articles for article (PubMed ID: 10827363)
1. [Drug-resistant malaria: problems with its definition and technical approaches].
Basco L; Ringwald P
Sante; 2000; 10(1):47-50. PubMed ID: 10827363
[TBL] [Abstract][Full Text] [Related]
2. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
Djaman J; Abouanou S; Basco L; Koné M
Sante; 2004; 14(4):205-9. PubMed ID: 15745869
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vivo and in vitro tests of resistance in patients treated with chloroquine in Yaoundé, Cameroon.
Ringwald P; Basco LK
Bull World Health Organ; 1999; 77(1):34-43. PubMed ID: 10063659
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
[TBL] [Abstract][Full Text] [Related]
5. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
6. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
[TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
Tahar R; Basco LK
Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen.
Al-Kabsi AM; Al-Shamahy HA; Al-Harazy AH; Harmal NS
Med Princ Pract; 2009; 18(1):62-6. PubMed ID: 19060494
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Nsimba B; Jafari-Guemouri S; Malonga DA; Mouata AM; Kiori J; Louya F; Yocka D; Malanda M; Durand R; Le Bras J
Trop Med Int Health; 2005 Oct; 10(10):1030-7. PubMed ID: 16185238
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
12. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
Durrani N; Leslie T; Rahim S; Graham K; Ahmad F; Rowland M
Trop Med Int Health; 2005 Jun; 10(6):521-9. PubMed ID: 15941414
[TBL] [Abstract][Full Text] [Related]
14. Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America.
Best Plummer W; Pinto Pereira L
Int J Infect Dis; 2008 Nov; 12(6):e27-31. PubMed ID: 18573671
[TBL] [Abstract][Full Text] [Related]
15. Overview: clinical pharmacology of antimalarials.
Karbwang J; Harinasuta T
Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():95-109. PubMed ID: 1364873
[TBL] [Abstract][Full Text] [Related]
16. [Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies].
Raharimalala AL; Randrianarivelojosia M; Randriamanantena A; Ranarivelo LA; Jaureguiberry S; Rason MA; Rakotomalala E; Ariey F
Arch Inst Pasteur Madagascar; 2000; 66(1-2):26-31. PubMed ID: 12463030
[TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
19. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
[TBL] [Abstract][Full Text] [Related]
20. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
Talisuna AO; Nalunkuma-Kazibwe A; Langi P; Mutabingwa TK; Watkins WW; Van Marck E; Egwang TG; D'Alessandro U
Infect Genet Evol; 2004 Dec; 4(4):321-7. PubMed ID: 15374529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
